Accès ouvert
2024
article
OpenAlex
Hirokazu Takami, Masao Matsutani, Tomonari Suzuki, Kazuhiko Takabatake et autres
BACKGROUND: A previous Phase II clinical trial, conducted from 1995 to 2003, evaluated CNS germ cell tumors (GCTs) using a three-group treatment stratification based on histopathology. The primary objective of the study was to assess the long-term efficacy of standardized treatment regimens, …
jp, us
(code pays fourni par la source)
Accès ouvert
2024
conference-abstract
OpenAlex
Hirokazu Takami, Ryo Nishikawa, Tomonari Suzuki, Kazuhiko Takabatake et autres
Abstract BACKGROUND This detailed examination merges outcomes from a Phase II clinical trial targeting central nervous system (CNS) germ cell tumors (GCTs) conducted between 1995 and 2003. It evaluates the impact of histopathologically driven treatment modalities on survival, recurrence, and post-treatment life …
jp
(code pays fourni par la source)
Accès ouvert
2024
article
OpenAlex
Kiyotaka Yokogami, Takashi Watanabe, Shinji Yamashita, Asako Mizuguchi et autres
PURPOSE: Meningiomas are the most common type of brain tumors and are generally benign, but malignant atypical meningiomas and anaplastic meningiomas frequently recur with poor prognosis. The metabolism of meningiomas is little known, so few effective treatment options other than surgery and …
jp
(code pays fourni par la source)
2024
article
OpenAlex
Fumitaka Matsumoto, Kiyotaka Yokogami, Ai Y. Yamada, Hiroshi Moritake et autres
jp
(code pays fourni par la source)
Accès ouvert
2024
preprint
OpenAlex
Kiyotaka Yokogami, Takashi Watanabe, Shinji Yamashita, Asako Mizuguchi et autres
Abstract Purpose. Meningiomas are the most common type of brain tumors and are generally benign, but malignant atypical meningiomas and anaplastic meningiomas frequently recur with poor prognosis. The metabolism of meningiomas is little known, so few effective treatment options other than surgery …
jp
(code pays fourni par la source)
Accès ouvert
2024
article
OpenAlex
Go Takeishi, Shinji Yamashita, Fumitaka Matsumoto, Kiyotaka Saito et autres
Advances in cancer treatment have improved the survival of patients with cancer, with a concomitant increase in the proportion of patients with metastatic brain tumors (MBTs). In this study, we used cancer registries established in Japan after 2016 and available patient data …
jp
(code pays fourni par la source)
Accès ouvert
2023
conference-abstract
OpenAlex
Hirokazu Takami Fulvio D'Angelo, Tomonari Suzuki, Kazuhiko Takabatake, Takamitsu Fujimaki et autres
Abstract BACKGROUND Phase II clinical trial funded by Ministry of Health, Labour and Welfare from 1995 to 2003 evaluated efficacy of pathology-based three-group treatment stratification for CNS germ cell tumors (GCTs). We here present long-term follow-up results. METHODS Total 228 cases were …
jp
(code pays fourni par la source)
Accès ouvert
2023
article
OpenAlex
Hirokazu Takami, Kaishi Satomi, Kohei Fukuoka, Taishi Nakamura et autres
We have previously reported that 12p gain may predict the presence of malignant components and poor prognosis for CNS germ cell tumor (GCT). Recently, 3p25.3 gain was identified as an independent predictor of poor prognosis for testicular GCT. Eighty-one CNS GCTs were …
jp
(code pays fourni par la source)
Accès ouvert
2023
article
OpenAlex
Souma Arikawa, Takashi Watanabe, Hideki Yamaguchi, Yuichiro Z. Sato et autres
BACKGROUND: Ameloblastic carcinoma (AC) is a rare odontogenic carcinoma with histological features resembling ameloblastoma. Metastasis to distant organs and direct expansion into the skull base structures are associated with a poor clinical outcome. This rare case of AC metastasis to the pituitary …
jp
(code pays fourni par la source)
Accès ouvert
2023
article
OpenAlex
Kiyotaka Yokogami, Takashi Watanabe, Aya Mizuguchi, Satoshi Yamashita et autres
Abstract BACKGROUND Although the majority of meningiomas are slow-growing and benign, atypical and anaplastic meningiomas behave aggressively with a penchant for recurrence. The 5-year risk of progression for incompletely resected meningiomas is over 80 percents. Specifically, the 5-year survival rates are 78-91% …
jp
(code pays fourni par la source)
Accès ouvert
2023
article
OpenAlex
Shinji Yamashita, Hideo Takeshima, Yoshihito Kadota, Minako Azuma et autres
Abstract BACKGROUND After the new molecular-based classification was reported to be useful for predicting prognosis, the T2-fluid-attenuated inversion recovery (FLAIR) mismatch sign has gained interest as one of the promising methods for detecting lower-grade gliomas (LGGs) with isocitrate dehydrogenase (IDH) mutations and …
jp
(code pays fourni par la source)
2023
article
OpenAlex
Ai Y. Yamada, Mariko Kinoshita, Sachiyo Kamimura, Takashi Jinnouchi et autres
Atypical teratoid/rhabdoid tumor (AT/RT) is a rare aggressive central nervous system tumor that typically affects children under three years old and has poor survival with a high risk for neurologic deficits. The primary purpose of this study was to successfully treat the …
jp
(code pays fourni par la source)